Association between drug prescribing and quality of life in primary care.
OBJECTIVE
To evaluate quality of life among patients of Family Health Strategy Units and how it relates to the prescribing complexity and to the number of psychotropic medications prescribed, including adjustments for sociodemographic characteristics.


METHODS
Family Health Strategy Units in a municipality in the Brazilian state of Rio Grande do Sul.


METHODS
Cross-sectional study using face-to-face interviews and prescribing analysis among users of Family Health Strategy Units. Patients were recruited by consecutive sampling. Multiple linear regression models were fitted to the different domains of quality of life in the WHOQOL-Bref questionnaire. The response rate for the patients who completed the interview was 97%. The prescribed medication data and sociodemographic characteristics of the sample were included as covariates. Prescribing complexity was analyzed by means of the Medication Regimen Complexity Index. The assumptions in the estimated models were tested and the models were validated.


METHODS
Quality of life among patients of Family Health Strategy Units.


RESULTS
At total, 336 patients answered the questionnaire. Through multiple linear regression, it was observed that higher prescribing complexity was associated with significantly low scores in the physical (-2.01, 95% CI = -2.89 to -1.35) and overall (-1.93, 95% CI = -2.81 to -0.99) quality of life domains. Greater amounts of psychotropic medications prescribed were associated with significantly low scores in the physical (-1.02, 95% CI = -1.29 to -0.56), psychological (-2.52, 95% CI = -3.15 to -1.65) and overall (-0.97, 95% CI = -2.06 to -0.33) domains of the interviewees' quality of life. The estimated models were adjusted for the sociodemographic characteristics of the sample and presented good predictive capacity.


CONCLUSIONS
The evaluated aspects of the prescribed medication (complexity and presence of psychotropic medications) were associated with low scores in the physical, psychological and overall quality of life domains. This may be an intrinsic characteristic of the interviewed patients, like having the quality of life at such a low level before starting the treatment, that the medication could not improve it to normal levels. Also, it can be a demonstration of the ineffectiveness of these treatments within primary health care.
Fröhlich
Samanta E
SE
Department of Epidemiology Program, Federal University of Rio Grande do Sul, Ipiranga Avenue, 2752, Porto Alegre, RS, 90610-000, Brazil. sasafras@terra.com.br
Zaccolo
Anamaria V
AV
da Silva
Sabrina L C
SL
Mengue
Sotero S
SS
D000293:Adolescent; D000328:Adult; D001938:Brazil; D003430:Cross-Sectional Studies; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care / Q000379:methods* / Q000639:trends; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011788:Quality of Life / Q000523:psychology*; D011795:Surveys and Questionnaires; D055815:Young Adult
D011619:Psychotropic Drugs
Arch Gen Psychiatry. 2001 Sep;58(9):869-76
11545671
Nord J Psychiatry. 2006;60(1):32-7
16500797
Psychosom Med. 2004 Jul-Aug;66(4):620-4
15272112
Milbank Q. 1996;74(4):511-44
8941260
J Clin Psychiatry. 2002;63 Suppl 8:17-23
12044104
Pharmacotherapy. 2001 Sep;21(9):1123-9
11560202
J Adv Nurs. 2005 Mar;49(6):616-23
15737222
J Clin Epidemiol. 2001 Sep;54(9):928-34
11520653
Rev Saude Publica. 2000 Apr;34(2):178-83
10881154
Eval Program Plann. 1983;6(3-4):185-210
10299618
Ann Pharmacother. 2004 Sep;38(9):1369-76
15266038
Rev Saude Publica. 2002 Aug;36(4):431-8
12364916
Qual Life Res. 2006 Feb;15(1):83-91
16411033
Ann Emerg Med. 2001 Dec;38(6):666-71
11719747
J Clin Epidemiol. 2001 Jul;54(7):661-74
11438406
Am J Psychiatry. 2004 Dec;161(12):2230-7
15569894
Psychol Med. 1998 May;28(3):551-8
9626712
Pharmacotherapy. 2006 Jun;26(6):768-78
16716130
J Intellect Disabil Res. 2005 Oct;49(Pt 10):707-17
16162115
Health Qual Life Outcomes. 2004 Sep 07;2:47
15353000
J Psychiatr Pract. 2005 Jan;11(1):5-15
15650617
JAMA. 2003 Jul 9;290(2):215-21
12851276
JAMA. 1992 Mar 18;267(11):1478-83
1538538
JAMA. 1995 Nov 15;274(19):1511-7
7474219
Aten Primaria. 2003 Mar 31;31(5):285-92; discussion 293-4
12681142
Milbank Q. 1989;67(3-4):450-84
2534562
Am J Hosp Pharm. 1989 May;46(5):929-44
2729301
Braz J Psychiatry. 2003 Oct;25(4):249-52
15328553
Public Health Nurs. 2005 Jan-Feb;22(1):36-44
15670323
Arq Bras Cardiol. 2007 Oct;89(4):210-8
17992376
Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):314-9
16611208
JAMA. 2003 Apr 2;289(13):1652-8
12672733
Image J Nurs Sch. 1991 Winter;23(4):231-5
1937521
Arch Fam Med. 2000 Feb;9(2):150-4
10693732
Gend Med. 2006 Jun;3(2):93-109
16860269